非晶合金(液态金属)
Search documents
宜安科技:预计2025年度净利润亏损1300万元~1800万元
Mei Ri Jing Ji Xin Wen· 2026-01-30 10:57
每经头条(nbdtoutiao)——中国无人驾驶"军团","武装"阿布扎比 (记者 曾健辉) 每经AI快讯,宜安科技1月30日晚间发布业绩预告,预计2025年归属于上市公司股东的净利润亏损1300 万元~1800万元,同比由盈转亏。业绩变动主要原因是,项目开发投入影响。报告期内,公司持续加大 项目开发投入力度,在非晶合金(液态金属)、生物可降解医用镁等领域持续投入,特别是围绕某重点 客户做了大幅的投入,影响业绩。汇率变动影响。公司约35%的营业收入来自出口业务,人民币持续升 值影响部分利润,影响业绩。非经常性损益变化影响。 ...
液态金属产业腾飞在即 宜安科技加快产能布局
Zheng Quan Ri Bao Wang· 2026-01-23 10:48
Core Viewpoint - Dongguan Yian Technology Co., Ltd. has signed a project agreement to establish a standard factory for the production of amorphous alloys, which is expected to enhance the company's core competitiveness and sustainable operational capacity [1][2]. Group 1: Project Development - The project involves leasing 132 acres of land and constructing a building area of 130,700 square meters for the amorphous alloy (liquid metal) benchmark project [1]. - The factory is scheduled to start construction within six months after delivery, with the first phase expected to be operational within 12 months and full production within 24 months [1]. Group 2: Market Demand and Applications - The demand for amorphous alloys is accelerating due to the rapid development of sectors such as foldable screens and new energy vehicles [1]. - Yian Technology's amorphous alloys are already being used in various fields, including as core materials for foldable screen hinges supplied to major brands like Huawei [2]. - The new base in Zhuzhou will enhance production capacity to meet the growing market demand for foldable smartphones and laptops [2]. Group 3: Technological Innovation - Yian Technology holds over 300 patents and 7 industry standards in the field of amorphous alloys, maintaining a product yield rate of over 90%, which establishes a strong technological barrier [2]. - The scale production at the Zhuzhou base is expected to reduce unit costs and strengthen price competitiveness while providing greater practical space for technological iteration [2]. Group 4: Industry Trends - The establishment of the Zhuzhou base reflects the rise of China's new materials industry driven by policy benefits and market demand [2]. - The company's strategic layout, including the adjustment of production capacity and the collaboration of three major bases, aligns closely with market trends and industry dynamics [2].
宜安科技:公司将聚焦主责主业,形成传统业务与新兴业务协同发展的双轮驱动模式
Zheng Quan Ri Bao Zhi Sheng· 2026-01-05 12:08
Core Viewpoint - The company aims to strengthen its core business while expanding into high-tech, high-value sectors to create a dual-driven development model [1] Group 1: Business Focus - The company will concentrate on stabilizing and solidifying its existing operations in magnesium-aluminum precision die casting to establish a strong foundation for growth [1] - The company plans to enhance and expand its high-tech offerings, including amorphous alloys (liquid metals) and biodegradable medical magnesium, to cultivate new growth momentum [1] Group 2: Strategic Development - The company is pursuing a dual-driven model that integrates traditional and emerging businesses for synergistic development [1]
宜安科技:镁铝轻质化合金一体化铸造是公司核心主营业务
Zheng Quan Ri Bao Zhi Sheng· 2025-11-10 09:41
Core Viewpoint - Yian Technology emphasizes its focus on magnesium-aluminum lightweight alloy integrated casting as its core business, targeting markets such as new energy vehicles, consumer electronics, communications, and medical devices [1] Group 1: Core Business - The core business of the company is magnesium-aluminum lightweight alloy integrated casting, primarily serving the new energy vehicle, consumer electronics, communications, and medical device markets [1] Group 2: Growth Business - Amorphous alloy (liquid metal) is identified as a growth business, targeting consumer electronics, medical devices, new energy vehicles, precision instruments, and high-quality musical instruments [1] Group 3: Future Industry - Biodegradable medical magnesium is a future industry being incubated by the company, aimed at markets such as implantable bone devices, ligament repair devices, and intestinal stents [1] Group 4: Strategic Focus - The company's strategy includes solidifying its core business, rapidly expanding its growth business through increased R&D investment to maintain technological leadership, and promoting the incubation of future industries to meet patient needs and benefit the public [1]